IPXL

Impax Laboratories, Inc. Press Releases

$27.8
*  
unch
unch
Get IPXL Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals
10/22/2014 4:04:00 PM - PR Newswire
▲2.62 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Impax To Acquire Tower Holdings, Inc. And Lineage Therapeutics Inc.
10/9/2014 6:00:00 AM - PR Newswire
▲16.61 % Price Change since this news event. The Volume Ratio is 8.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lieff Cabraser Reminds Impax Laboratories, Inc. Investors of Upcoming Deadline in Class Action Litigation – IPXL
10/7/2014 2:59:00 PM - Business Wire


Impax Laboratories to Announce Results for Third Quarter 2014 on November 4
10/7/2014 8:35:00 AM - PR Newswire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Impax Laboratories, Inc. (IPXL) To Contact The Firm
10/1/2014 4:00:00 PM - PR Newswire


Impax Pharmaceuticals Announces Extension of RYTARY™ FDA Review Date to January 9, 2015
9/17/2014 9:00:00 AM - PR Newswire


Deadline in Lawsuit for Investors in Impax Laboratories Inc (IPXL) Shares Announced by Shareholders Foundation
9/16/2014 11:30:00 AM - GlobeNewswire


SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Impax Laboratories, Inc. and Certain Officers - IPXL
9/12/2014 3:55:00 PM - PR Newswire


Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Impax Laboratories, Inc. -- IPXL
8/26/2014 3:14:00 PM - GlobeNewswire


Lieff Cabraser Announces Class Action Litigation Against Impax Laboratories, Inc. - IPXL
8/25/2014 1:56:00 PM - Business Wire


Pomerantz Law Firm Announces the Filing of a Class Action Against Impax Laboratories, Inc. and Certain Officers -- IPXL
8/13/2014 6:33:00 PM - GlobeNewswire


Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., Peoples Federal Bancshares, Inc. and Siuslaw Financial Group, Inc.
8/8/2014 2:15:00 PM - PR Newswire


Impax's Second Quarter 2014 Revenues Increased 45% to $188.1 Million
8/6/2014 7:30:00 AM - PR Newswire


FDA Performs Inspection of Impax's Hayward Facility
8/4/2014 8:30:00 AM - PR Newswire


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL
7/29/2014 2:30:00 PM - PR Newswire


FDA Performs Inspection of Impax's Taiwan Facility
7/29/2014 8:05:00 AM - PR Newswire